Forensic Analysis · Health Care
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
A forensic read on Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
41.1
P / E
2.6%
ROE
$2.2B
Market cap
4.07%
Dividend yield
The full forensic report — free
🔒Every red flag on TAK, detailed and traced to the filing
🔒Altman Z distress & Beneish M earnings-quality screens
🔒Calibrated 12-month price forecast + reverse-DCF
🔒Earnings-quality & capital-allocation forensics
No credit card · informational only, not investment advice
← Browse all forensic stock analyses
Data from SEC EDGAR public filings. Forensic signals flag probability, not certainty.